Veterinary Medicines

Ruvax Vet Suspensie voor injectie

Not authorised
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Download as PDF

Product identification

Medicine name:
Ruvax Vet Suspensie voor injectie
Ruvax Vet Suspension injectable
Ruvax Vet Injektionssuspension
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Belgium
Package description:
  • Ruvax Vet 50 ml Vial Suspension for injection
  • Ruvax Vet 200 ml Vial Suspension for injection
  • Ruvax Vet 20 ml Vial Suspension for injection
  • Ruvax Vet 10 ml Vial Suspension for injection
  • Ruvax Vet 2 ml Vial Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
This information is not available for this product.
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V140646
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."